Expert Interviews Archives - Psych Scene Hub

February 9, 2019

Typical Response & Remission Rates of rTMS in Treatment Resistant Cases – Dr. Martijn Arns
Dr Sanil Rege, Consultant Psychiatrist and Founder of Psych Scene and Psych Scene Hub speaks to Dr. Martijn Arns, Chief Scientific Adviser, ...
READ MORE
February 9, 2019

Key Differences Between rTMS and Electroconvulsive Therapy (ECT) – Dr. Martijn Arns
Dr Sanil Rege, Consultant Psychiatrist and Founder of Psych Scene and Psych Scene Hub speaks to Dr. Martijn Arns, Chief Scientific Adviser, ...
READ MORE
Dr Vinay Lakra
January 21, 2019

Time to read: 8 minutes

Inside the Mind of a Deputy Chief Psychiatrist – Interview with Dr Vinay Lakra
Dr Vinay Lakra is the Deputy Chief Psychiatrist of Victoria and Clinical Director of the North West Area Mental Health Service, North Western Mental Hea...
READ MORE
January 16, 2019

Protected: Outcome of Major Depression, Choice of Antidepressants and the Importance of Shared Decision Making – Prof Demyttenaere
Speaker Bio: Prof Koen Demyttenaere, M.D., Ph.D. serves as the Chair of the Department of Psychiatry in the University Psychiatr...
READ MORE
December 27, 2018

Repetitive Transcranial Magnetic Stimulation (rTMS) in Depression – Conversations with Dr Martijn Arns, Neuromodulation Expert
Dr Sanil Rege, Consultant Psychiatrist and Founder of Psych Scene and Psych Scene Hub speaks to Dr. Martijn Arns, Chief Scientific Adviser, neuroCare Gr...
READ MORE
December 18, 2018

What are the Reasons for the Rise in Interest in Neuromodulation? – Conversations with Dr Martijn Arns, Neuromodulation Expert
Dr Sanil Rege, Consultant Psychiatrist and Founder of Psych Scene and Psych Scene Hub...
READ MORE
December 17, 2018

How Did You Get Interested in the Field of Neuromodulation? – Conversations with Dr Martijn Arns, Neuromodulation Expert
Dr Sanil Rege, Consultant Psychiatrist and Founder of Psych Scene and Psych Scene H...
READ MORE
September 20, 2018

Protected: Metabolic and Cardiovascular Risks with Antipsychotics – How Can Clinicians Make a Difference?
Speaker Bio: Christoph Correll, MD, is professor of Psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/N...
READ MORE
August 15, 2018

Protected: The Impact of Medication Adverse Effects on Quality of Life in Schizophrenia
Short author bio Christoph Correll, MD, is professor of Psychiatry at the Donald and Barbara Zucker School of Medicine at Hofst...
READ MORE
July 6, 2018

Protected: Use of Metabolically Friendly Antipsychotics; Depression & Cognition in Schizophrenia
Short author bio Christoph Correll, MD, is professor of Psychiatry at the Donald and Barbara Zucker School of Medicine at Hofst...
READ MORE

Typical Response & Remission Rates of rTMS in Treatment Resistant Cases – Dr. Martijn Arns

Key Differences Between rTMS and Electroconvulsive Therapy (ECT) – Dr. Martijn Arns

Inside the Mind of a Deputy Chief Psychiatrist – Interview with Dr Vinay Lakra

Protected: Outcome of Major Depression, Choice of Antidepressants and the Importance of Shared Decision Making – Prof Demyttenaere

Repetitive Transcranial Magnetic Stimulation (rTMS) in Depression – Conversations with Dr Martijn Arns, Neuromodulation Expert

What are the Reasons for the Rise in Interest in Neuromodulation? – Conversations with Dr Martijn Arns, Neuromodulation Expert

How Did You Get Interested in the Field of Neuromodulation? – Conversations with Dr Martijn Arns, Neuromodulation Expert

Protected: Metabolic and Cardiovascular Risks with Antipsychotics – How Can Clinicians Make a Difference?

Protected: The Impact of Medication Adverse Effects on Quality of Life in Schizophrenia

Protected: Use of Metabolically Friendly Antipsychotics; Depression & Cognition in Schizophrenia

About Knowledge Hub

Recent Comments

Let’s Connect

Typical Response & Remission Rates of rTMS in Treatment Resistant Cases – Dr. Martijn Arns

Key Differences Between rTMS and Electroconvulsive Therapy (ECT) – Dr. Martijn Arns

Inside the Mind of a Deputy Chief Psychiatrist – Interview with Dr Vinay Lakra

Protected: Outcome of Major Depression, Choice of Antidepressants and the Importance of Shared Decision Making – Prof Demyttenaere

Repetitive Transcranial Magnetic Stimulation (rTMS) in Depression – Conversations with Dr Martijn Arns, Neuromodulation Expert

What are the Reasons for the Rise in Interest in Neuromodulation? – Conversations with Dr Martijn Arns, Neuromodulation Expert

How Did You Get Interested in the Field of Neuromodulation? – Conversations with Dr Martijn Arns, Neuromodulation Expert

Protected: Metabolic and Cardiovascular Risks with Antipsychotics – How Can Clinicians Make a Difference?

Protected: The Impact of Medication Adverse Effects on Quality of Life in Schizophrenia

Protected: Use of Metabolically Friendly Antipsychotics; Depression & Cognition in Schizophrenia

BECOME A HUBSTER! JOIN 5000+ SUBSCRIBERS

About Knowledge Hub

Recent Comments

Let’s Connect